DCM
DAFNA Capital Management Portfolio holdings
AUM
$362M
This Quarter Return
-8.66%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$419M
AUM Growth
+$419M
(-4.7%)
Cap. Flow
+$1.35M
Cap. Flow
% of AUM
0.32%
Top 10 Holdings %
Top 10 Hldgs %
47.79%
Holding
85
New
13
Increased
17
Reduced
18
Closed
2
Top Buys
| 1 |
AtriCure
ATRC
|
$8.38M |
| 2 |
UroGen Pharma
URGN
|
$7.87M |
| 3 |
Biohaven
BHVN
|
$3.47M |
| 4 |
Alkermes
ALKS
|
$2.91M |
| 5 |
SLRN
ACELYRIN
SLRN
|
$2.17M |
Top Sells
| 1 |
Perspective Therapeutics
CATX
|
$28.6M |
| 2 |
Procept Biorobotics
PRCT
|
$2.5M |
| 3 |
Tandem Diabetes Care
TNDM
|
$2.18M |
| 4 |
Ascendis Pharma
ASND
|
$1.57M |
| 5 |
BioNTech
BNTX
|
$1.57M |
Sector Composition
| 1 | Healthcare | 85.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Oric Pharmaceuticals
ORIC
$1.02B
| $255K | 0.06% |
+36,000
| New | +$255K |
|
77
Foghorn Therapeutics
FHTX
$301M
| $241K | 0.06% |
+41,850
| New | +$241K |
|
|
NVRO
78
DELISTED
NEVRO CORP.
NVRO
| $236K | 0.06% |
28,000
| – | – |
|
79
Structure Therapeutics
GPCR
$1.18B
| $196K | 0.05% |
+5,000
| New | +$196K |
|
80
Karyopharm Therapeutics
KPTI
$59M
| $167K | 0.04% |
192,678
| – | – |
|
81
Spero Therapeutics
SPRO
$117M
| $163K | 0.04% |
125,000
| – | – |
|
82
Compass Therapeutics
CMPX
$470M
| $117K | 0.03% |
116,882
| – | – |
|
|
83
BioNTech
BNTX
$24.1B
| – | – |
-17,000
| Closed | -$1.57M |
|
|
VIGL
84
DELISTED
Vigil Neuroscience
VIGL
| – | – |
-71,815
| Closed | -$245K |
|